Treatment outcomes in cytomegalovirus anterior uveitis
- Conditions
- Cytomegalovirus anterior uveitisCMVTreatment outcomesViral anterior uveitis
- Registration Number
- TCTR20230401002
- Lead Sponsor
- /A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 75
1.Patients with signs and symptoms which are compatible with cytomegalovirus anterior uveitis
2.Patients with aqueous PCR positive for cytomegalovirus
3.Patients who was treated with topical or systemic ganciclovir
1.Patients who were diagnosed as CMV intermediate uveitis or CMV retinitits
2.Patients who were diagnosed as uveitis from other causes e.g. Infection, Autoimmune disease, Idiopathic
3.Patients with aqueous PCR positive for other organism or mixed organism
4.Patients who were treated with combination therapy
5.Immunocompromised patients
6.Patients with age under 18
7.In case of failure in first treatment protocol and other treatments were introduced. Data collection will select only first treatment protocol as failure of treatment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response to treatment when response or failure to treatment was noted Percentage of response
- Secondary Outcome Measures
Name Time Method Time to response duration from starting of treatment to the time when resolution of A/C cell is documented duration from starting of treatment to the time when resolution of A/C cell is documented,Time to recurrence When next episode of inflammation happened uration from starting of treatment to the time when next episode of inflammation happened,Visual acuity When respond or fail to treatment Visual acuity measurement by ETDRS chart,IOP When respond or fail to treatment Air puff tonometer and Application tonometry